Masimo Co. (NASDAQ:MASI) Shares Sold by Exchange Traded Concepts LLC

Exchange Traded Concepts LLC lowered its position in shares of Masimo Co. (NASDAQ:MASI) by 15.9% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 10,552 shares of the medical equipment provider’s stock after selling 1,998 shares during the period. Exchange Traded Concepts LLC’s holdings in Masimo were worth $1,744,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently added to or reduced their stakes in the company. UMB Bank n.a. increased its stake in Masimo by 180.9% during the fourth quarter. UMB Bank n.a. now owns 191 shares of the medical equipment provider’s stock worth $32,000 after acquiring an additional 123 shares during the last quarter. Trust Co. of Vermont acquired a new stake in shares of Masimo during the 4th quarter worth about $33,000. NBC Securities Inc. raised its holdings in Masimo by 47.1% in the 3rd quarter. NBC Securities Inc. now owns 228 shares of the medical equipment provider’s stock valued at $30,000 after buying an additional 73 shares during the period. Northwestern Mutual Wealth Management Co. lifted its position in Masimo by 133.3% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 350 shares of the medical equipment provider’s stock valued at $44,000 after buying an additional 200 shares during the last quarter. Finally, GAMMA Investing LLC boosted its stake in Masimo by 136.5% during the fourth quarter. GAMMA Investing LLC now owns 466 shares of the medical equipment provider’s stock worth $77,000 after buying an additional 269 shares during the period. 85.96% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on MASI. Wells Fargo & Company boosted their price target on shares of Masimo from $171.00 to $193.00 and gave the company an “overweight” rating in a research note on Wednesday, December 11th. Stifel Nicolaus restated a “buy” rating and set a $190.00 price target (up from $170.00) on shares of Masimo in a research note on Friday, November 22nd. BTIG Research raised their price target on Masimo from $166.00 to $170.00 and gave the stock a “buy” rating in a research report on Monday, October 14th. Needham & Company LLC reiterated a “hold” rating on shares of Masimo in a report on Wednesday, January 22nd. Finally, Raymond James lifted their target price on Masimo from $170.00 to $194.00 and gave the company an “outperform” rating in a research report on Friday, December 27th. Three investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $179.67.

Masimo Price Performance

Shares of NASDAQ MASI opened at $170.24 on Monday. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.01 and a quick ratio of 1.11. The company has a market cap of $9.11 billion, a price-to-earnings ratio of 117.41 and a beta of 1.01. The stock’s 50-day moving average is $170.32 and its two-hundred day moving average is $142.65. Masimo Co. has a 1-year low of $101.61 and a 1-year high of $180.97.

Masimo (NASDAQ:MASI) last issued its earnings results on Tuesday, November 5th. The medical equipment provider reported $0.98 earnings per share for the quarter, beating the consensus estimate of $0.84 by $0.14. Masimo had a net margin of 3.85% and a return on equity of 14.98%. The firm had revenue of $504.60 million for the quarter, compared to analysts’ expectations of $502.87 million. During the same quarter last year, the company earned $0.63 earnings per share. The firm’s revenue was up 5.4% compared to the same quarter last year. Analysts forecast that Masimo Co. will post 4.1 EPS for the current fiscal year.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.